142 related articles for article (PubMed ID: 38446573)
1. Enduring Consensus Guidelines for Cervical Cancer Screening and Management: Introduction to the Scope and Process.
Wentzensen N; Garcia F; Clarke MA; Massad LS; Cheung LC; Egemen D; Guido R; Huh W; Saslow D; Smith RA; Unger ER; Perkins RB;
J Low Genit Tract Dis; 2024 Apr; 28(2):117-123. PubMed ID: 38446573
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
4. Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories.
Nayar R; Chhieng DC; Crothers B; Darragh TM; Davey DD; Eisenhut C; Goulart R; Huang EC; Tabbara SO
J Am Soc Cytopathol; 2020; 9(4):291-303. PubMed ID: 32565297
[TBL] [Abstract][Full Text] [Related]
5. No. 385-Indications for Pelvic Examination.
Evans D; Goldstein S; Loewy A; Altman AD
J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
[TBL] [Abstract][Full Text] [Related]
6. Risk-Based Cervical Consensus Guidelines: Methods to Determine Management if Less Than 5 Years of Data Are Available.
Egemen D; Perkins RB; Clarke MA; Guido R; Huh W; Saraiya M; Saslow D; Smith R; Unger ER; Garcia F; Wentzensen N; Cheung LC;
J Low Genit Tract Dis; 2022 Jul; 26(3):195-201. PubMed ID: 35763610
[TBL] [Abstract][Full Text] [Related]
7. 2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation.
Cheung LC; Egemen D; Chen X; Katki HA; Demarco M; Wiser AL; Perkins RB; Guido RS; Wentzensen N; Schiffman M
J Low Genit Tract Dis; 2020 Apr; 24(2):90-101. PubMed ID: 32243306
[TBL] [Abstract][Full Text] [Related]
8. Recommendations for Use of p16/Ki67 Dual Stain for Management of Individuals Testing Positive for Human Papillomavirus.
Clarke MA; Wentzensen N; Perkins RB; Garcia F; Arrindell D; Chelmow D; Cheung LC; Darragh TM; Egemen D; Guido R; Huh W; Locke A; Lorey TS; Nayar R; Risley C; Saslow D; Smith RA; Unger ER; Massad LS;
J Low Genit Tract Dis; 2024 Apr; 28(2):124-130. PubMed ID: 38446575
[TBL] [Abstract][Full Text] [Related]
9. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
Della Palma P; Moresco L; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
[TBL] [Abstract][Full Text] [Related]
10. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
[TBL] [Abstract][Full Text] [Related]
12. Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines.
Egemen D; Cheung LC; Chen X; Demarco M; Perkins RB; Kinney W; Poitras N; Befano B; Locke A; Guido RS; Wiser AL; Gage JC; Katki HA; Wentzensen N; Castle PE; Schiffman M; Lorey TS
J Low Genit Tract Dis; 2020 Apr; 24(2):132-143. PubMed ID: 32243308
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.
Fontham ETH; Wolf AMD; Church TR; Etzioni R; Flowers CR; Herzig A; Guerra CE; Oeffinger KC; Shih YT; Walter LC; Kim JJ; Andrews KS; DeSantis CE; Fedewa SA; Manassaram-Baptiste D; Saslow D; Wender RC; Smith RA
CA Cancer J Clin; 2020 Sep; 70(5):321-346. PubMed ID: 32729638
[TBL] [Abstract][Full Text] [Related]
14. A cross-sectional survey examining clinician characteristics, practices, and attitudes associated with adoption of the 2019 American Society for Colposcopy and Cervical Pathology risk-based management consensus guidelines.
Vadaparampil ST; Fuzzell LN; Brownstein NC; Fontenot HB; Lake P; Michel A; McIntyre M; Whitmer A; Perkins RB
Cancer; 2023 Sep; 129(17):2671-2684. PubMed ID: 37221653
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of the 2019 American Society for Colposcopy and Cervical Pathology Risk-Based Management Consensus Guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.
Munshi VN; Perkins RB; Sy S; Kim JJ
Am J Obstet Gynecol; 2022 Feb; 226(2):228.e1-228.e9. PubMed ID: 34547295
[TBL] [Abstract][Full Text] [Related]
16. Risk of cervical precancer and cancer among uninsured and underserved women from 2009 to 2017.
Saraiya M; Cheung LC; Soman A; Mix J; Kenney K; Chen X; Perkins RB; Schiffman M; Wentzensen N; Miller J
Am J Obstet Gynecol; 2021 Apr; 224(4):366.e1-366.e32. PubMed ID: 33035473
[TBL] [Abstract][Full Text] [Related]
17. Clinical Practice Guidelines on the Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention in Saudi Arabia.
Al-Mandeel HM; Sagr E; Sait K; Latifah HM; Al-Obaid A; Al-Badawi IA; Alkushi AO; Salem H; Massoudi NS; Schunemann H; Mustafa RA; Brignardello-Petersen R
Ann Saudi Med; 2016; 36(5):313-320. PubMed ID: 27710981
[TBL] [Abstract][Full Text] [Related]
18. Global strategies for cervical cancer prevention and screening.
Pimple SA; Mishra GA
Minerva Ginecol; 2019 Aug; 71(4):313-320. PubMed ID: 30808155
[TBL] [Abstract][Full Text] [Related]
19. Practice Bulletin No. 168: Cervical Cancer Screening and Prevention.
Obstet Gynecol; 2016 Oct; 128(4):e111-e130. PubMed ID: 27661651
[TBL] [Abstract][Full Text] [Related]
20. Summary of Current Guidelines for Cervical Cancer Screening and Management of Abnormal Test Results: 2016-2020.
Perkins RB; Guido RL; Saraiya M; Sawaya GF; Wentzensen N; Schiffman M; Feldman S
J Womens Health (Larchmt); 2021 Jan; 30(1):5-13. PubMed ID: 33464997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
